Spiegelberg H L, Perlmann H, Perlmann P
J Immunol. 1976 Nov;117(5 Pt 1):1464-71.
Human myeloma proteins of the four IgG subclasses and their Fc, F(ab)2, and Fab fragments were tested for their ability to inhibit antibody-dependent human K lymphocyte-mediated cytotoxicity to chicken erythrocytes (CRBC) sensitized with specific rabbit antibodies. In addition, the adsorption of K cells onto glass bead columns coated with myeloma proteins was investigated. Myeloma proteins and their Fc fragments of all four subclasses inhibited K cell activity. However, there were wide variations within a given subclass and IgG2 and IgG4 proteins usually inhibited less than IgG1 and IgG3 proteins. Aggregation of the weakly inhibitory proteins with bis-diazotized benzidine increased their inhibitory effect. An IgG1 half-molecule with a deletion in the Cgamma3 domain was weakly inhibitory. Passage of lymphocytes through glass bead columns coated with IgG1 and IgG3 proteins removed K cell activity. In contrast, columns coated with IgG2 and IgG4 proteins, even when aggregated with BDB, failed to absorb K cells but removed significant numbers of SIg positive B lymphocytes. An enhancement of the antibody-dependent cytotoxicity was observed in 34% of the inhibition experiments in the presence of low concentrations of the weakly inhibitory proteins, usually IgG2 and IgG4. This enhancement occurred more frequently (53% of the experiments) with Fc fragments independent of the subclass. Moreover, addition of IgG2 and IgG4 but not IgG1 and IgC3 fragments induced a dose-dependent cytotoxicity to CRBC in the absence of anti-CRBC antibodies. These data indicate that IgG2 and IgG4 proteins have a lower affinity to K cells than IgG1 and IgG3 proteins and are compatible with an earlier hypothesis that proposes that more than one site on the Fc fragment can react with Fc receptors. The present results suggest in addition that there may be functionally different sites, one having a triggering function in K lymphocyte lysis that may be localized on the second constant domain and one being responsible for high affinity binding of IgG to cell receptors that is probably localized on the third constant domain.
对四种IgG亚类的人骨髓瘤蛋白及其Fc、F(ab)2和Fab片段进行了测试,以检测它们抑制抗体依赖性人K淋巴细胞对用特异性兔抗体致敏的鸡红细胞(CRBC)的细胞毒性的能力。此外,还研究了K细胞在包被有骨髓瘤蛋白的玻璃珠柱上的吸附情况。所有四个亚类的骨髓瘤蛋白及其Fc片段均抑制K细胞活性。然而,在给定亚类中存在很大差异,IgG2和IgG4蛋白的抑制作用通常小于IgG1和IgG3蛋白。用双偶氮联苯胺使弱抑制性蛋白聚集可增强其抑制作用。在Cγ3结构域有缺失的IgG1半分子具有弱抑制性。淋巴细胞通过包被有IgG1和IgG3蛋白的玻璃珠柱后,K细胞活性消失。相反,包被有IgG2和IgG4蛋白的柱,即使与双偶氮联苯胺聚集,也不能吸附K细胞,但能去除大量表面免疫球蛋白(SIg)阳性的B淋巴细胞。在低浓度弱抑制性蛋白(通常为IgG2和IgG4)存在的情况下,34%的抑制实验中观察到抗体依赖性细胞毒性增强。这种增强在Fc片段的实验中更频繁出现(53%的实验),且与亚类无关。此外,在没有抗CRBC抗体的情况下,添加IgG2和IgG4片段而非IgG1和IgG3片段会诱导对CRBC的剂量依赖性细胞毒性。这些数据表明,IgG2和IgG4蛋白与K细胞的亲和力低于IgG1和IgG3蛋白,这与早期提出的Fc片段上不止一个位点可与Fc受体反应的假设相符。目前的结果还表明,可能存在功能不同的位点,一个在K淋巴细胞裂解中具有触发功能,可能位于第二个恒定结构域,另一个负责IgG与细胞受体的高亲和力结合,可能位于第三个恒定结构域。